Arkolith/Insider Trading/RNXT/Form 4

Agah Ramtin

Chief Medical Officer, DirectorRenovoRx, Inc. (RNXT) · full profile →Form 4 · filed Apr 16, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 14, 2025Grant(A)255K—$0255K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001641172-25-005106) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML